E. Groeneveld
Impact in
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
Papers in
-
- Protease and Inhibitor Mechanisms 17
-
- Blood Coagulation and Thrombosis Mechanisms 7
- Co-authors
- D.C. Rijken (10 shared papers)G. Wijngaards (7 shared papers)C. Kluft (1 shared paper)W. Nieuwenhuizen (3 shared papers)J. P. A. van den Bergh (2 shared papers)C.M. ten Bruggenkate (2 shared papers)P. Holzmann (1 shared paper)D.B. Tuinzing (1 shared paper)
- Journals
- Thrombosis and Haemostasis (4 papers)Journal of Biomedical Materials Research (2 papers)Journal of Clinical Investigation (2 papers)Thrombosis Research (2 papers)British Journal of Haematology (1 paper)
- Partner nations
- NetherlandsUnited States
In The Last Decade
E. Groeneveld
19 papers receiving 406 citations
Peers
Comparison fields: 5 of 62
- Hematology 225
- Cancer Research 238
- Oral Surgery 62
- Biotechnology 66
- Internal Medicine 24
Countries citing papers authored by E. Groeneveld
This map shows the geographic impact of E. Groeneveld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Groeneveld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Groeneveld more than expected).
Fields of papers citing papers by E. Groeneveld
This network shows the impact of papers produced by E. Groeneveld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Groeneveld. The network helps show where E. Groeneveld may publish in the future.
Co-authors
The 23 scholars most cited alongside E. Groeneveld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 93 | |
| 2 | 1982 | 62 | |
| 3 | 1986 | 57 | |
| 4 | 1991 | 44 | |
| 5 | 1987 | 39 | |
| 6 | 1977 | 29 | |
| 7 | 1986 | 23 | |
| 8 | 1991 | 22 | |
| 9 | 1993 | 20 | |
| 10 | Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin. | 1988 | 19 |
| 11 | 1977 | 17 | |
| 12 | 1994 | 10 | |
| 13 | 1993 | 10 | |
| 14 | 1978 | 9 | |
| 15 | 1999 | 8 | |
| 16 | 1985 | 7 | |
| 17 | 1995 | 5 | |
| 18 | 2002 | 3 | |
| 19 | 1988 | 3 |
About E. Groeneveld
E. Groeneveld is a scholar working on Cancer Research, Hematology, Pulmonary and Respiratory Medicine, Biotechnology and Molecular Biology, having authored 19 papers that have together received 480 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (17 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers), Enzyme Production and Characterization (5 papers), Blood properties and coagulation (5 papers), Peptidase Inhibition and Analysis (4 papers), Signaling Pathways in Disease (2 papers), Dental Implant Techniques and Outcomes (2 papers) and Periodontal Regeneration and Treatments (2 papers). The work is most often cited by research in Hematology (225 citations), Cancer Research (238 citations), Oral Surgery (62 citations), Biotechnology (66 citations) and Internal Medicine (24 citations). E. Groeneveld has collaborated with scholars based in Netherlands and United States. Frequent co-authors include D.C. Rijken, G. Wijngaards, C. Kluft, W. Nieuwenhuizen, J. P. A. van den Bergh, C.M. ten Bruggenkate, P. Holzmann, D.B. Tuinzing, Elisabeth H. Burger and Cornelis Kluft. Their work appears in journals such as Thrombosis and Haemostasis, Journal of Biomedical Materials Research, Journal of Clinical Investigation, Thrombosis Research and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.